105 related articles for article (PubMed ID: 26376351)
1. Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.
Isakoff MS; Goldsby R; Villaluna D; Krailo MD; Gorlick R; Doski JJ; Womer RB; Janeway KA
Pediatr Blood Cancer; 2016 Feb; 63(2):370-1. PubMed ID: 26376351
[No Abstract] [Full Text] [Related]
2. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.
Isakoff MS; Goldsby R; Villaluna D; Krailo MD; Hingorani P; Collier A; Morris CD; Kolb EA; Doski JJ; Womer RB; Gorlick R; Janeway KA
Pediatr Blood Cancer; 2019 Feb; 66(2):e27524. PubMed ID: 30378256
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.
Lagmay JP; Krailo MD; Dang H; Kim A; Hawkins DS; Beaty O; Widemann BC; Zwerdling T; Bomgaars L; Langevin AM; Grier HE; Weigel B; Blaney SM; Gorlick R; Janeway KA
J Clin Oncol; 2016 Sep; 34(25):3031-8. PubMed ID: 27400942
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy of osteosarcoma: no runs, no hits, two men left on base.
Holland JF
J Clin Oncol; 1987 Jan; 5(1):4-6. PubMed ID: 3543237
[No Abstract] [Full Text] [Related]
6. [Chemotherapy of osteosarcomas].
Kalifa C; Rubie H; Lemerle J
Chir Pediatr; 1985; 26(4):233-7. PubMed ID: 3907873
[No Abstract] [Full Text] [Related]
7. Phase II window studies: 10 years of experience and counting.
Smith MA; Anderson B
J Pediatr Hematol Oncol; 2001; 23(6):334-7. PubMed ID: 11563765
[No Abstract] [Full Text] [Related]
8. Seeking enrolment for a new treatment for canine osteosarcoma.
Polton G; Dunning M
J Small Anim Pract; 2015 Jul; 56(7):481. PubMed ID: 26134604
[No Abstract] [Full Text] [Related]
9. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
Prindull G; Poppe H; Jentsch E; Schauer A
Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
[No Abstract] [Full Text] [Related]
10. Osteosarcoma: the state of affairs dictates a change. What do we know?
Kleinerman ES; Mary V; John A
Adv Exp Med Biol; 2014; 804():vii-viii. PubMed ID: 25207354
[No Abstract] [Full Text] [Related]
11. Emerging drugs for high-grade osteosarcoma.
Hattinger CM; Pasello M; Ferrari S; Picci P; Serra M
Expert Opin Emerg Drugs; 2010 Dec; 15(4):615-34. PubMed ID: 20690888
[TBL] [Abstract][Full Text] [Related]
12. The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma.
Pawinski A; Crowther D; Keizer HJ; Voûte PA; Somers R; van Glabbeke M; Lentz MA; van Oosterom AT
Eur J Cancer; 1999 Jan; 35(1):163-4. PubMed ID: 10211107
[No Abstract] [Full Text] [Related]
13. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Schwartz CL; Wexler LH; Krailo MD; Teot LA; Devidas M; Steinherz LJ; Goorin AM; Gebhardt MC; Healey JH; Sato JK; Meyers PA; Grier HE; Bernstein ML; Lipshultz SE
Pediatr Blood Cancer; 2016 Jan; 63(1):54-61. PubMed ID: 26398490
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the management of bone tumors--1996.
Craft AW
Ann N Y Acad Sci; 1997 Sep; 824():167-79. PubMed ID: 9382441
[No Abstract] [Full Text] [Related]
15. Osteosarcoma -- surgery, radiotherapy and chemotherapy.
Flatman GE
Radiography; 1978 Feb; 44(518):35-40. PubMed ID: 272705
[No Abstract] [Full Text] [Related]
16. [Recent aspects of osteosarcoma therapy].
Hoffken K; Schmidt CG
Dtsch Med Wochenschr; 1976 Feb; 101(7):251-8. PubMed ID: 765088
[No Abstract] [Full Text] [Related]
17. [Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)].
Krizan Z; Makai F; Krizan I; Blasková L; Látal J; Majeský B
Acta Chir Orthop Traumatol Cech; 1979 Feb; 46(1):26-8. PubMed ID: 88152
[No Abstract] [Full Text] [Related]
18. [Results of Primary chemotherapy and Delayed Surgical Resection in Osteosarcoma (author's transl)].
Urban C; Kotz R; Mutz ID; Seewann H
Wien Klin Wochenschr; 1981 Mar; 93(5):155-63. PubMed ID: 6944967
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
Bond M; Bernstein ML; Pappo A; Schultz KR; Krailo M; Blaney SM; Adamson PC
Pediatr Blood Cancer; 2008 Feb; 50(2):254-8. PubMed ID: 17262795
[TBL] [Abstract][Full Text] [Related]
20. [Pre-surgical continuous arterial infusion of antineoplastic agents in osteosarcoma].
Oe H
Igaku Kenkyu; 1971 Jul; 41(5):353-63. PubMed ID: 5287045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
